Faculty

Institution

Unit

Venue

Elise Nassif Haddad

The University of Texas MD Anderson Cancer Center

Affiliations

Departments Of Sarcoma Medical Oncology And Paediatrics

The University of Texas MD Anderson Cancer Center

NoneElise Nassif Haddad is currently serving as a Departments Of Sarcoma Medical Oncology And Paediatrics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elise Nassif Haddad

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

immunology oncology sarcoma immune checkpoint inhibitors cancer immunotherapy immunotherapy cancer cells pathology cancer research cellular therapy molecular cancer tumor microenvironment oncogenes cancer discovery tumor targeting cancer treatment malignant disease cancer genetics immune checkpoint blockade radiology pharmacology immune responses metagenomics surgical oncology medicinal research surgical pathology clinical investigation cancer imaging cancer letter molecular diagnostics molecular gastroenterology digestive diseases gut microbes enzyme inhibition therapeutic efficacy cancer biology clinical immunology immunopathology cancer immunosurveillance immunological biomarkers therapy resistance dietary fibre gastrointestinal oncology immunomodulation therapeutic vaccines gut-organ axis dysbiosis oncogenic agent neoadjuvant immune-checkpoint blockade immune infiltrates clinical outcomes nut sarcomas therapeutic strategies comprehensive review immune infiltration hyalinization-based pathologic response immune-checkpoint blockade b-cell receptor sarcoma patients dynamic biomarker solid cancers tertiary lymphoid structures dietary fiber

Notable Scholarly Works

Notable Federal Grants

Collaborators

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With Kit Exon 9 Mutations. JAMA Oncology (2026)

cancer geneticsradiation oncologymolecular cancercancer discoverymesotheliomamolecular gastroenterologymolecular diagnosticsoncologygastroenterologyoncogenesgastrointestinal oncologygastrointestinal stromal tumorscancer letteradjuvant imatinibpathology

High Dietary Fiber is Associated With Improved Outcomes in Patients With Melanoma and Sarcoma Treated With Immunotherapy Regardless of Gut Microbiome Dysbiosis and Social Vulnerability. Cancer (2026)

immunologymicrobiomegut microbesdigestive diseasesgut-organ axissocial vulnerabilityhigh dietary fiberdysbiosisimmunotherapy regardlessnutritionhealth sciences

Abstract 7124: Imaging Mass Cytometry (Imc) Reveals Distinct Intratumoral B and T Regulatory Cell Populations in Responder Versus Non-Responder Soft Tissue Sarcoma (Sts) Patients Before Treatment With Immune Checkpoint Blockade (Icb). Cancer Research (2025)

Laurence P. DiggsElise Nassif HaddadSusmita KumariVarshini ArunkumarSammy Ferri-BorgognoSamuel MokDuncan MakAngelique LinMadeline McAllisterAkshay BasiManoj ChelvanambiJavier GomezJared BurksDavis IngramKhalida WaniNatalie DuarteTrevor McKeeAlexander LazarJennifer WargoChristina RolandEmily Keung

immunologyimmune checkpoint blockadecancer researchimmune checkpoint inhibitorscancer imagingsarcoma

Advancing Understanding and Therapeutic Strategies for Nut Sarcomas: Comprehensive Review of the Literature and Two Cases. Journal of Immunotherapy and Precision Oncology (2025)

cancer researchmalignant diseasecomprehensive reviewtherapeutic strategiesoncologysarcomanut sarcomassurgical pathologypathology

Antibodies Derived From Patient Tumors Augment Response to Immune Checkpoint Blockade in Cancer 3582. The Journal of Immunology (2025)

immunologycheckpoint blockademolecular cancerimmune checkpoint inhibitorscancer immunotherapytherapeutic targetscancer cellsimmunomodulationcancer 3582cellular therapytherapeutic vaccinesimmunotherapycell biology

Hyalinization-Based Pathologic Response and Immune Infiltration Following Neoadjuvant Radiotherapy With or Without Immune-Checkpoint Blockade in Localized Undifferentiated Pleomorphic Sarcoma. ESMO Open (2025)

immunologyimmune-checkpoint blockadehyalinization-based pathologic responseradiation oncologyimmune checkpoint inhibitorscancer immunosurveillancemalignant diseaseoncologysarcomacancer cellstumor microenvironmentpathologycellular therapyimmune infiltrationimmunotherapy

Poly(Adenosine Diphosphate Ribose) Polymerase Inhibition in Isocitrate Dehydrogenase 1 and 2–Mutant Tumors: Bridging Science With the Clinic. Cancer (2025)

cancer geneticsoncogenic agentpathologybiochemistrymolecular cancerenzymesnucleic acidscancer researchtranscription (biology)therapeutic targetstumor biologyenzyme inhibitioncancer discoverymolecular biologyoncogenescancer cellsbridging sciencepolymerase inhibitionadenosine diphosphate ribose

A Randomized, Non-Comparative Phase 2 Study of Neoadjuvant Immune-Checkpoint Blockade in Retroperitoneal Dedifferentiated Liposarcoma and Extremity/Truncal Undifferentiated Pleomorphic Sarcoma. Nature Cancer (2024)

Christina L. RolandElise F. Nassif HaddadEmily Z. KeungWei-Lien WangAlexander J. LazarHeather LinManoj ChelvanambiEdwin R. ParraKhalida WaniB. Ashleigh GuadagnoloAndrew J. BishopElizabeth M. BurtonKelly K. HuntKeila E. TorresBarry W. FeigChristopher P. ScallyValerae O. LewisJustin E. BirdRavin RatanDejka AraujoM. Alexandra ZarzourShreyaskumar PatelRobert BenjaminAnthony P. ConleyJ. Andrew LivingstonVinod RaviHussein A. TawbiPatrick P. LinBryan S. MoonRobert L. SatcherBilal MujtabaRussell G. WittRaymond S. TraweekBrandon CopeRossana LazcanoChia-Chin WuXiao ZhouMohammad M. MohammadRandy A. ChuJianhua ZhangAshish DamaniaPranoti SahasrabhojaneTaylor TateKate CallahanSa NguyenDavis IngramRohini MoreyShadarra CrosbyGrace MathewSheila DuncanCibelle F. LimaJean-Yves BlayWolf Herman FridmanKenna ShawIgnacio WistubaAndrew FutrealNadim AjamiJennifer A. WargoNeeta Somaiah

immunologytumor targetingradiologypharmacologyneoadjuvant immune-checkpoint blockadecancer researchimmune checkpoint inhibitorssurgical oncologytherapeutic efficacycancer immunotherapysarcomaoncologymedicinal researchcancer cellscancer treatmentcancer biologycellular therapyimmunotherapy

542 B-Cell Receptor (Bcr) Repertoire is a Dynamic Biomarker of Survival in Sarcoma Patients Treated With Neoadjuvant Immune Checkpoint Blockade (Icb). Regular and Young Investigator Award Abstracts (2022)

Elise NassifBin LiuWei-Lien WangAlexander LazarDavis IngramKhalida WaniSheila DuncanTaylor TateGrace MathewShadarra CrosbyKenna ShawMonika ZelazowskaBarry FeigKeila TorresKelly HuntB Ashleigh GuadagnoloAndrew BishopPhillip Andrew FutrealJennifer WargoNeeta SomaiahKevin McBrideChristina RolandEmily Keung

immunologyimmunological biomarkersimmune checkpoint inhibitorscancer immunotherapytherapy resistanceb-cell receptorbiostatisticssarcomaoncologyimmune responsessarcoma patientsclinical investigationdynamic biomarkerimmunotherapy

590 Metagenomic Sequencing Reveals Unique Gut Microbial Features Associated With Tertiary Lymphoid Structures in Response to Immune Checkpoint Blockade in Solid Cancers. Regular and Young Investigator Award Abstracts (2022)

Manoj ChelvanambiNathaniel DeboeverElise NassifAshish DamaniaLili ChenCheuk LeungEmily KeungChia-Chin WuRussell WittMichael WhiteSarah JohnsonMatthew WongAditya MishraMatthew LastrapesNeeta SomaiahHumam KadaraSreyashi BasuJames AllisonPadmanee SharmaKevin McBrideWolf FridmanJohn HeymachBoris SepesiNadim AjamiChristina RolandJennifer WargoTina Cascone

immunologytertiary lymphoid structuresmetagenomicscancer immunotherapyoncologysolid cancers

1
2
10 / page

Elise Nassif Haddad

The University of Texas MD Anderson Cancer Center

Affiliations

Departments Of Sarcoma Medical Oncology And Paediatrics

The University of Texas MD Anderson Cancer Center

NoneElise Nassif Haddad is currently serving as a Departments Of Sarcoma Medical Oncology And Paediatrics faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Elise Nassif Haddad

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With Kit Exon 9 Mutations. JAMA Oncology (2026)

immunologymicrobiomegut microbesdigestive diseasesgut-organ axissocial vulnerabilityhigh dietary fiberdysbiosisimmunotherapy regardlessnutritionhealth sciences

immunologyimmune checkpoint blockadecancer researchimmune checkpoint inhibitorscancer imagingsarcoma

Advancing Understanding and Therapeutic Strategies for Nut Sarcomas: Comprehensive Review of the Literature and Two Cases. Journal of Immunotherapy and Precision Oncology (2025)

cancer researchmalignant diseasecomprehensive reviewtherapeutic strategiesoncologysarcomanut sarcomassurgical pathologypathology

Antibodies Derived From Patient Tumors Augment Response to Immune Checkpoint Blockade in Cancer 3582. The Journal of Immunology (2025)

Poly(Adenosine Diphosphate Ribose) Polymerase Inhibition in Isocitrate Dehydrogenase 1 and 2–Mutant Tumors: Bridging Science With the Clinic. Cancer (2025)

immunologytertiary lymphoid structuresmetagenomicscancer immunotherapyoncologysolid cancers

1
2
10 / page